Investor Relations

We maintain a transparent, comprehensive dialogue with the financial community about our strategy, outlook, financial data, economic environment, and social impact.

Fourth quarter and full year 2023 results

Fourth quarter and full year 2023 results were reviewed by management during a live audio webcast with the financial community on February 1st, 2024. The presentation was followed by a Q&A session.

Upcoming events

4Mar

2024

TD Cowen 44th Annual Health Care Conference

Naimish Patel, Global Head of Development for Immunology and Inflammation & Erik Wallstroem, Head of Development, Neurology presenting at TD Cowen’s 44th Annual Health Care Conference.
Fireside Chat : 12:50 – 1:20pm ET

12:50 - 13:20 ET

Broker Conference

Discover more

12Mar

2024

Leerink Partners Global Biopharma Conference 2024

Naimish Patel, Global Head of Development for Immunology and Inflammation & Shaju Backer, Global Head of Immunology Franchise presenting at Leerink Partners Global Biopharma Conference 2024.
Fireside Chat : 10:40am – 11:10am ET

10:40 - 11:10 ET

Broker Conference

Discover more

13Mar

2024

Barclays 26th Annual Global Healthcare Conference

Naimish Patel, Global Head of Development for Immunology and Inflammation & Shaju Backer, Global Head of Immunology Franchise presenting at Barclays 26th Annual Global Healthcare Conference.
Fireside Chat : 8:00 AM - 8:25 AM ET

08:00 - 08:25 ET

Broker Conference

Discover more

Press releases

February 24, 2024
Press Release: Phase 2 results demonstrate rilzabrutinib rapidly reduced itch severity and significantly improved disease activity in adults with chronic spontaneous urticaria
February 24, 2024
Media Update: Dupixent® continues scientific leadership with late-breaking results showing reduced airway inflammation and mucus plugging in adults with uncontrolled moderate-to-severe asthma
February 23, 2024
Press Release: Filing of the 2023 U.S. Form 20-F and French “Document d’Enregistrement Universel” containing the Annual Financial Report
Dr. Lingaraju checks the health of Manikantan as his sister Geetha watches closely inside the Billigiri Ranganathaswamy Temple Tiger Reserve in Chamrajanagara district, Karnataka state, India
Dr. Lingaraju checks the health of Manikantan as his sister Geetha watches closely inside the Billigiri Ranganathaswamy Temple Tiger Reserve in Chamrajanagara district, Karnataka state, India

Environment, Social, Governance

As a global pharmaceutical company, we stretch everyday to deliver safe and sustainable innovation and play our part in addressing some of the world’s most pressing challenges.

Contact Our Investor Relations Team

To join the Sanofi front desk,

Please contact the Global Headquarters in France :
+33 (0)1 53 77 40 00

To contact the Investor Relations team:

46 avenue de la Grande Armée
75017 Paris FRANCE
investor.relations (at) sanofi.com